{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:56:30Z","timestamp":1764766590004,"version":"3.46.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gofs.2025.10.016","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:23:55Z","timestamp":1760073835000},"page":"671-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quelles indications de la Progest\u00e9rone dans les populations \u00e0 risque d\u2019accouchement pr\u00e9matur\u00e9 en 2025\u00a0?"],"prefix":"10.1016","volume":"53","author":[{"given":"Ninon","family":"Dupuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Vayssi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gofs.2025.10.016_bib0155","doi-asserted-by":"crossref","first-page":"102509","DOI":"10.1016\/j.jogoh.2022.102509","article-title":"Collaborators - Members of the ENP2021 Study Group. Results of the 2021 French National Perinatal Survey and trends in perinatal health in metropolitan France since 1995","volume":"51","author":"Le Ray","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.016_bib0160","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ajog.2016.07.013","article-title":"Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.016_bib0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2015.12.010","article-title":"Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth","volume":"214","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.016_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajog.2011.03.048","article-title":"Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate","volume":"205","author":"Manuck","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.016_bib0175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2022.04.023","article-title":"Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis","volume":"227","author":"Conde-Agudelo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"08","key":"10.1016\/j.gofs.2025.10.016_bib0180","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/a-0854-6472","article-title":"Progesterone for the Prevention of Preterm Birth\u2013an Update of Evidence-Based Indications","volume":"79","author":"Kuon","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"8","key":"10.1016\/j.gofs.2025.10.016_bib0185","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jgyn.2015.06.011","article-title":"Progest\u00e9rone et pr\u00e9vention de l\u2019accouchement pr\u00e9matur\u00e9","volume":"44","author":"Fuchs","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2025.10.016_bib0190","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jogc.2019.04.012","article-title":"Guideline No 398: Progesterone for Prevention of Spontaneous Preterm Birth","volume":"42","author":"Jain","year":"2020","journal-title":"J Obstet Gynaecol Canada"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.016_bib0195","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/AOG.0000000000004479","article-title":"Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234","volume":"138","author":"Prediction","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.016_bib0200","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2024.05.006","article-title":"SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth","volume":"231","author":"Biggio","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.10.016_bib0205","unstructured":"2022 exceptional surveillance of preterm labour and birth (NICE guideline NG25) [Internet]. London: National Institute for Health and Care Excellence (NICE); 2022 [cited 2025 Apr 28]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK591661\/."},{"key":"10.1016\/j.gofs.2025.10.016_bib0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejogrb.2016.12.035","article-title":"Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF)","volume":"210","author":"Sentilhes","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.016_bib0215","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.012","article-title":"Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone, caproate","volume":"229","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"10033","key":"10.1016\/j.gofs.2025.10.016_bib0220","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gofs.2025.10.016_bib0225","doi-asserted-by":"crossref","first-page":"e015402","DOI":"10.1136\/bmjopen-2016-015402","article-title":"Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis","volume":"7","author":"Phillips","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.016_bib0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/1471-0528.15566","article-title":"Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis","volume":"126","author":"Jarde","year":"2019","journal-title":"BJOG"},{"issue":"10280","key":"10.1016\/j.gofs.2025.10.016_bib0235","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(21)00217-8","article-title":"Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials","volume":"397","author":"Group","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gofs.2025.10.016_bib0240","doi-asserted-by":"crossref","first-page":"e1002390","DOI":"10.1371\/journal.pmed.1002390","article-title":"Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.016_bib0245","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.012","article-title":"Electronic address: pubs@smfm.org, SMFM Publications Committee. Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone caproate","volume":"229","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.016_bib0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajog.2020.06.050","article-title":"Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial","volume":"224","author":"Rehal","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.016_bib0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/uog.24839","article-title":"Vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations with a short cervix: an updated individual patient data meta-analysis","volume":"59","author":"Romero","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.10.016_bib0260","unstructured":"Progesterone for preventing spontaneous preterm birth in twin and triplet pregnancy: Twin and triplet pregnancy: Evidence review K [Internet]. London: National Institute for Health and Care Excellence (NICE); 2024 [cited 2025 Apr 2]. (NICE Evidence Reviews Collection). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK604076\/."},{"key":"10.1016\/j.gofs.2025.10.016_bib0265","unstructured":"Likis FE, Andrews JC, Woodworth AL, Velez Edwards DR, Jerome RN, Fonnesbeck CJ, et al. Progestogens for Prevention of Preterm Birth [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 [cited 2025 Mar 29]. (AHRQ Comparative Effectiveness Reviews). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK109368\/."},{"issue":"2","key":"10.1016\/j.gofs.2025.10.016_bib0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.016_bib0275","first-page":"11","article-title":"Evaluation of the effect of progesterone on prevention of preterm delivery and its complications","volume":"14","author":"Akbari","year":"2009","journal-title":"SJKU"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.016_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.29252\/ijrm.14.5.309","article-title":"Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study","volume":"14","author":"Azargoon","year":"2016","journal-title":"IJRM"},{"issue":"7","key":"10.1016\/j.gofs.2025.10.016_bib0285","doi-asserted-by":"crossref","first-page":"e2419894","DOI":"10.1001\/jamanetworkopen.2024.19894","article-title":"Vaginal Progesterone for Pregnancy Prolongation After Arrested Preterm Labor: A Randomized Clinical Trial","volume":"7","author":"Nachum","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.016_bib0290","article-title":"Progestational agents for treating threatened or established preterm labour","volume":"2014","author":"Su","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2025.10.016_bib0295","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/1471-0528.17499","article-title":"Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysis","volume":"130","author":"Breuking","year":"2023","journal-title":"BJOG"},{"issue":"25","key":"10.1016\/j.gofs.2025.10.016_bib0150","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1080\/14767058.2021.1963705","article-title":"Vaginal progesterone for preterm birth prevention in women with arrested preterm labor","volume":"35","author":"Frey","year":"2022","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925003484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925003484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:42:57Z","timestamp":1764765777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718925003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2468718925003484"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2025.10.016","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quelles indications de la Progest\u00e9rone dans les populations \u00e0 risque d\u2019accouchement pr\u00e9matur\u00e9 en 2025\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2025.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}